T1	Participants 55 89	patients with head and neck cancer
T2	Participants 401 527	January 1995 until July 1999, 124 patients with histologically proven locally advanced non-nasopharyngeal head and neck cancer
T3	Participants 1168 1185	At 3 yr follow-up
T4	Participants 1621 1655	patients with locally advanced HNC
